Evans, M., Dejager, S., Schweizer, A., & Foley, J. E. (2015). Is There Evidence of Any Safety Differences Among DPP-4 Inhibitors in the Treatment of People with Type 2 Diabetes Mellitus and Reduced GFR Due to Chronic Kidney Disease? Diabetes Ther.
Style de citation ChicagoEvans, Marc, Sylvie Dejager, Anja Schweizer, et James E. Foley. "Is There Evidence of Any Safety Differences Among DPP-4 Inhibitors in the Treatment of People With Type 2 Diabetes Mellitus and Reduced GFR Due to Chronic Kidney Disease?" Diabetes Ther 2015.
Style de citation MLAEvans, Marc, Sylvie Dejager, Anja Schweizer, et James E. Foley. "Is There Evidence of Any Safety Differences Among DPP-4 Inhibitors in the Treatment of People With Type 2 Diabetes Mellitus and Reduced GFR Due to Chronic Kidney Disease?" Diabetes Ther 2015.